🔗 Permalink

Inventor profile of:

Michael Wacker

City:

Unterengstringen

Country:

Switzerland

Published Applications:

Last publication date:

2024-08-22

Top Assignees for applications by Michael Wacker

The entities that hold a legal rights for patent applications filed by inventor Wacker Michael:

GLYCOVAXYN AG 8 Schlieren, Switzerland
GlaxoSmithKline Biologicals S.A. 7 Rixensart, Belgium
GLYCOVAXYN AG 2 , Switzerland
ISIS INNOVATION LIMITED 1 Oxford, United Kingdom
GLYCOVAXYN AG 1 Schileren, Switzerland
ETH ZURICH 1 Zurich, Switzerland
ETH ZÜRICH 1 Zürich, Switzerland
GlycoVaxyn AG 1 Chlieren, Switzerland
GlaxoSmithKline Biologicals SA 1 , Belgium

Recent patent applications by Wacker Michael

Michael Wacker from Unterengstringen, CH has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-08-22

US20240277824A1

Human necessities

BIOCONJUGATES MADE FROM RECOMBINANT N-GLYCOSYLATED PROTEINS FROM PROCARYOTIC CELLS

#2 | 2022-06-16

US20220186196A1

Chemistry; metallurgy

Methods of Host Cell Modification

#3 | 2022-01-27

US20220025419A1

Chemistry; metallurgy

N-GLYCOSYLATION OF PEPTIDES AND PROTEINS

#4 | 2021-03-25

US20210085772A1

Human necessities

Bioconjugates made from recombinant N-glycosylated proteins from procaryotic cells

#5 | 2019-07-18

US20190218561A1

Chemistry; metallurgy

METHODS OF HOST CELL MODIFICATION

#6 | 2019-03-14

US20190076517A1

Human necessities

Production of recombinant vaccine in by enzymatic conjugation

#7 | 2017-05-11

US20170128559A1

Human necessities

Capsular gram-positive bacteria bioconjugate vaccines

#8 | 2017-05-04

US20170121691A1

Chemistry; metallurgy

Methods of host cell modification

#9 | 2016-10-20

US20160303213A1

Human necessities

Prevention of infections by glycoprotein vaccines synthesized in

#10 | 2016-09-08

US20160257983A1

Chemistry; metallurgy

N-GLYCOSYLATION OF PEPTIDES AND PROTEINS

#11 | 2015-10-01

US20150273043A1

Human necessities

PRODUCTION OF RECOMBINANT VACCINE IN E.COLI BY ENZYMATIC CONJUGATION

#12 | 2015-09-24

US20150267207A1

Chemistry; metallurgy

METHODS OF HOST CELL MODIFICATION

#13 | 2015-08-27

US20150238596A1

Human necessities

BIOCONJUGATES COMPRISING MODIFIED ANTIGENS AND USES THEREOF

#14 | 2015-07-09

US20150190492A1

Human necessities

Biosynthetic system that produces immunogenic polysaccharides in prokaryotic cells

#15 | 2015-02-12

US20150044254A1

Human necessities

Bioconjugates made from recombinant N-glycosylated proteins from procaryotic cells

#16 | 2015-01-08

US20150010592A1

Human necessities

Capsular gram-positive bacteria bioconjugate vaccines

#17 | 2014-11-13

US20140335127A1

Chemistry; metallurgy

SYSTEM AND METHOD FOR THE PRODUCTION OF RECOMBINANT GLYCOSYLATED PROTEINS IN A PROKARYOTIC HOST

#18 | 2013-01-31

US20130028926A1

Human necessities

Biosynthetic system that produces immunogenic polysaccharides in prokaryotic cells

#19 | 2011-11-10

US20110274720A1

Human necessities

Capsular gram-positive bacteria bioconjugate vaccines

#20 | 2011-04-28

US20110097357A1

Human necessities

Bioconjugates made from recombinant N-glycosylated proteins from procaryotic cells

#21 | 2009-03-19

US20090074798A1

Chemistry; metallurgy

System and method for the production of recombinant glycosylated proteins in a prokaryotic host

InventorID:

65924 ⎘